IPP Bureau
AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments
By IPP Bureau - January 14, 2022
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
South Korea approves Novavax Covid-19 vaccine
By IPP Bureau - January 13, 2022
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
Metropolis Healthcare opens MedEngage Scholarship programme
By IPP Bureau - January 13, 2022
The last date to apply for this program is 18th January 2022
Normalised quarter with impending margin pressure: ICICI Direct
By IPP Bureau - January 13, 2022
ICICI Direct gives a preview on the earnings narrative for Q3FY22
Cipla wins Frost & Sullivan and Teri Sustainability award for `Challenger in Mega Large Business Pharma Sector’
By IPP Bureau - January 13, 2022
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
BioGenex RT-PCR Kit detects all Covid variants in half the time
By IPP Bureau - January 13, 2022
This test analyses samples in VTM directly without the need for RNA extraction step
AstraZeneca studies show its booster effective against all variants
By IPP Bureau - January 13, 2022
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons
By IPP Bureau - January 13, 2022
KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales
Merck KGaA appoints Global R&D Head & CSO for healthcare business sector
By IPP Bureau - January 13, 2022
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
Veristat supported marketing applications for 12 % of all FDA Novel Drug Approvals in 2021
By IPP Bureau - January 12, 2022
This surpasses the number of approvals supported in 2020
Novel preventive vaccine for Parkinson’s move into human trials
By IPP Bureau - January 12, 2022
MultiTEP Platform-based vaccine targeting three B cell epitopes of pathological ?-Synuclein simultaneously shows protective efficacy in mouse model of synucleinopathies
Amgen and Arrakis collaborate for small molecule therapeutics
By IPP Bureau - January 12, 2022
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
Indian pharma industry registers 5.3% YoY revenue growth in Dec 2021 : Ind-Ra
By IPP Bureau - January 12, 2022
Ind-Ra expects revenue growth of over 12% in 2022.
Marksons Pharma receive final US. FDA approval for Cetirizine Hydrochloride tablets
By IPP Bureau - January 12, 2022
The product will be marketed under store brand labels and is comparable to the brand Zyrtec
Sinocompound and InCatT launch new Catalyst Screening Service
By IPP Bureau - January 12, 2022
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
